Production (Stage)
Organogenesis Holdings Inc.
ORGO
$3.03
$0.155.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -797.29% | 1,450.88% | 289.48% | -420.60% | 29.27% |
| Total Depreciation and Amortization | 7.88% | 5.63% | 16.72% | 21.49% | 1.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 76.94% | -41.86% | -14.24% | 287.38% | 49.56% |
| Change in Net Operating Assets | -0.05% | -155.62% | -558.09% | -14.25% | -75.04% |
| Cash from Operations | -96.17% | 3.04% | -48.04% | -45.20% | -100.16% |
| Capital Expenditure | -63.19% | -1.11% | 57.03% | 74.93% | 70.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -63.19% | -1.11% | 57.03% | 74.93% | 70.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 82.91% | -3,421.99% | -17.05% | -64.02% | -77.83% |
| Issuance of Common Stock | -86.11% | 106,200.00% | -- | -- | -- |
| Repurchase of Common Stock | -60.36% | -- | -- | -58.82% | -275.84% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 21.17% | 1,993.58% | -16.62% | -63.85% | -111.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -70.87% | 647.78% | -52.25% | 1,116.13% | -8.05% |